TY  - JOUR
AU  - Karimian-Jazi, Kianush
AU  - Enbergs, Noah
AU  - Golubtsov, Evgeny
AU  - Schregel, Katharina
AU  - Ungermann, Johannes
AU  - Fels-Palesandro, Hannah
AU  - Schwarz, Daniel
AU  - Sturm, Volker
AU  - Kernbach, Julius M
AU  - Batra, David
AU  - Ippen, Franziska
AU  - Pflüger, Irada
AU  - von Knebel Doeberitz, Nikolaus
AU  - Heiland, Sabine
AU  - Bunse, Lukas
AU  - Platten, Michael
AU  - Winkler, Frank
AU  - Wick, Wolfgang
AU  - Paech, Daniel
AU  - Bendszus, Martin
AU  - Breckwoldt, Michael
TI  - Differentiating Glioma Recurrence and Pseudoprogression by APTw CEST MRI.
JO  - Investigative radiology
VL  - 60
IS  - 6
SN  - 0020-9996
CY  - [Erscheinungsort nicht ermittelbar]
PB  - Ovid
M1  - DKFZ-2024-02553
SP  - 414-422
PY  - 2025
N1  - #EA:B320#LA:D170# / 2025 Jun 1;60(6):414-422
AB  - Recurrent glioma is highly treatment resistant due to its metabolic, cellular, and molecular heterogeneity and invasiveness. Tumor monitoring by conventional MRI has shortcomings to assess these key glioma characteristics. Recent studies introduced chemical exchange saturation transfer for metabolic imaging in oncology and assessed its diagnostic value for newly diagnosed glioma. This prospective study investigates amide proton transfer-weighted (APTw) MRI at 3 T as an imaging biomarker to elucidate the molecular heterogeneity and invasion patterns of recurrent glioma in comparison to pseudoprogression (PsPD).We performed a monocenter, prospective trial and screened 371 glioma patients who received tumor monitoring between August 2021 and March 2024 at our institution. The study included IDH wildtype astrocytoma and IDH mutant astrocytoma and oligodendroglioma, graded according to the WHO 2021 classification. Patients had received clinical standard of care treatment including surgical resection and radiochemotherapy prior to study inclusion. Patients were monitored by 3 monthly MRI follow-up imaging, and response assessment was performed according to the RANO criteria. Within this cohort, we identified 30 patients who presented with recurrent glioma and 12 patients with PsPD. In addition to standard anatomical sequences (FLAIR and T1-w Gd-enhanced sequences), MRI included APTw imaging. After sequence co-registration, semiautomated segmentation was performed of the FLAIR lesion, CE lesion, resection cavity, and the contralateral normal-appearing white matter, and APTw signals were quantified in these regions of interest.APTw values were highest in solid, Gd-enhancing tumor parts as compared with the nonenhancing FLAIR lesion (APTw: 1.99
LB  - PUB:(DE-HGF)16
C6  - pmid:39644107
DO  - DOI:10.1097/RLI.0000000000001145
UR  - https://inrepo02.dkfz.de/record/294843
ER  -